155 related articles for article (PubMed ID: 10953303)
1. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines.
Shao ZM; Shen ZZ; Fontana JA; Barsky SH
Anticancer Res; 2000; 20(4):2409-16. PubMed ID: 10953303
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism].
Di GH; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1764-8. PubMed ID: 14642080
[TBL] [Abstract][Full Text] [Related]
3. Curcumin exerts multiple suppressive effects on human breast carcinoma cells.
Shao ZM; Shen ZZ; Liu CH; Sartippour MR; Go VL; Heber D; Nguyen M
Int J Cancer; 2002 Mar; 98(2):234-40. PubMed ID: 11857414
[TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines.
Shao ZM; Wu J; Shen ZZ; Barsky SH
Anticancer Res; 1998; 18(3A):1435-9. PubMed ID: 9673352
[TBL] [Abstract][Full Text] [Related]
5. Genistein exerts multiple suppressive effects on human breast carcinoma cells.
Shao ZM; Wu J; Shen ZZ; Barsky SH
Cancer Res; 1998 Nov; 58(21):4851-7. PubMed ID: 9809990
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S
Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892
[TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis.
Shao ZM; Alpaugh ML; Fontana JA; Barsky SH
J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
[TBL] [Abstract][Full Text] [Related]
9. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
10. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
He FJ; Wang J; Niu JZ; Wang JF
Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
[TBL] [Abstract][Full Text] [Related]
11. Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells.
Chen GC; Guan LS; Hu WL; Wang ZY
Anticancer Res; 2002; 22(2A):633-8. PubMed ID: 12014631
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.
Hsieh CY; Santell RC; Haslam SZ; Helferich WG
Cancer Res; 1998 Sep; 58(17):3833-8. PubMed ID: 9731492
[TBL] [Abstract][Full Text] [Related]
13. IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways.
Mitropoulou TN; Theocharis AD; Nikitovic D; Karamanos NK; Tzanakakis GN
Biochimie; 2004; 86(4-5):251-9. PubMed ID: 15194227
[TBL] [Abstract][Full Text] [Related]
14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
15. Flavonoid effects relevant to cancer.
Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
[TBL] [Abstract][Full Text] [Related]
16. [Genistein induced apoptosis in MCF-7 and T47D cells].
Yu Z; Zhang L; Wu D
Wei Sheng Yan Jiu; 2003 Mar; 32(2):125-7. PubMed ID: 12793002
[TBL] [Abstract][Full Text] [Related]
17. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
